LCMV gp33–41
This is the H-2Db restricted epitope derived from the lymphocytic choreomeningitis virus (LCMV) glycoprotein gp 33; residues 33 to 41.
| ￥500 | |
| RP20257 | |
|
|
|
|
|
|
|
|
|
| ￥500 | |
| RP20257 | |
|
|
|
|
|
|
|
|
|
| Description | This is the H-2Db restricted epitope derived from the lymphocytic choreomeningitis virus (LCMV) glycoprotein gp 33; residues 33 to 41. |
| Sequence |
{Lys}{Ala}{Val}{Tyr}{Asn}{Phe}{Ala}{Thr}{Met} |
| Sequence Shortening | KAVYNFATM |
| Molecular Formula | C48H73N11O13S |
| Molecular Weight | 1044.25 |
| Purity | > 95% |
| Solubility | Soluble in dimethyl sulfoxide(Analytical grade) under 1mg/ml |
| Form | Lyophilized |
